Article

Paeoniflorin Attenuates Dexamethasone-Induced Apoptosis of Osteoblast Cells and Promotes…

Evidence-Based Complementary and Alternative Medicine · 2020 · Liyu Yang, author Shengye Liu, author Shuai Mu, author Ran Guo, author Long Zhou, author Qin Fu, author Jianping Chen, Academic Editor

Key facts

Title Paeoniflorin Attenuates Dexamethasone-Induced Apoptosis of Osteoblast Cells and Promotes Bone Formation via Regulating AKT/mTOR/Autophagy Signaling Pathway
First author Liyu Yang, author Shengye Liu, author Shuai Mu, author Ran Guo, author Long Zhou, author Qin Fu, author Jianping Chen, Academic Editor
Journal Evidence-Based Complementary and Alternative Medicine
Published Nov 26, 2020
DOI 10.1155/2021/6623464
Devices mentioned K843077, K843710
Product codes mentioned DGC, LGC, JCJ

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature